Rhumbline Advisers Morpho Sys Ag Transaction History
Rhumbline Advisers
- $109 Billion
- Q3 2024
A detailed history of Rhumbline Advisers transactions in Morpho Sys Ag stock. As of the latest transaction made, Rhumbline Advisers holds 5,187 shares of MOR stock, worth $0. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,187
Previous 5,187
-0.0%
Holding current value
$0
Previous $94,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding MOR
# of Institutions
13Shares Held
1.8MCall Options Held
0Put Options Held
14.7K-
Black Rock Inc. New York, NY1.02MShares$00.0% of portfolio
-
Segantii Capital Management LTD463KShares$01.04% of portfolio
-
Tekla Capital Management LLC177KShares$00.05% of portfolio
-
Hennion & Walsh Asset Management, Inc.123KShares$00.0% of portfolio
-
Simplex Trading, LLC4.46KShares$00.0% of portfolio
About MorphoSys AG
- Ticker MOR
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 136,614,000
- Description
- MorphoSys AG, a commercial-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic antibodies for patients suffering from cancer and autoimmune diseases in the United States. It offers Tafasitamab, an antibody for the treatment of B cell malignancies, including diffuse large B-cell lymphoma, f...